A61K 31/525
Isoalloxazines
Official title: Isoalloxazines, e.g. riboflavins, vitamin B2
A61K31/525 (Isoalloxazines) appears on 658 US grants and 1,427 published applications in this corpus.
Search patents in A61K- Granted patents
- 658
- Published applications
- 1,427
- Assignees
- 547
- Inventors
- 1,961
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 7 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 7 | 0 |
| 2001 | 9 | 3 |
| 2002 | 4 | 25 |
| 2003 | 16 | 58 |
| 2004 | 11 | 57 |
| 2005 | 15 | 72 |
| 2006 | 13 | 83 |
| 2007 | 9 | 77 |
| 2008 | 14 | 57 |
| 2009 | 18 | 45 |
| 2010 | 19 | 47 |
| 2011 | 23 | 44 |
| 2012 | 27 | 30 |
| 2013 | 20 | 47 |
| 2014 | 16 | 49 |
| 2015 | 26 | 54 |
| 2016 | 25 | 68 |
| 2017 | 32 | 54 |
| 2018 | 33 | 56 |
| 2019 | 34 | 58 |
| 2020 | 40 | 47 |
| 2021 | 37 | 79 |
| 2022 | 50 | 81 |
| 2023 | 23 | 86 |
| 2024 | 41 | 52 |
| 2025 | 23 | 40 |
| 2026 | 20 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of increasing the population of Dialister spp. in the gut microbiome8 Sep 2026US 12,728,109 B2Dsm IP Assets B.V.
- Powdered food supplement for producing a beverage1 Sep 2026US 12,721,878 B2PM-International AG
- Compounds and compositions for eye treatments7 Jul 2026US 12,673,925 B2Avedro, Inc.
- Controlled release concentrate and suspensions including the same16 Jun 2026US 12,653,782 B2Nulixir Inc.
- Benzimidazolone-based cinnamamide derivative as TRPV1 antagonist and pharmaceutical composition for treatment or prevention of pain containing same as active ingredient16 Jun 2026US 12,653,814 B2Jmackem Co., Ltd
- Compositions, Kits, and Methods Comprising Bioidentical D BHB With Optional Vitamin B6 for Neurological Wellness, Mood Stability, and Medication Taper Support8 Oct 2026US 2026/0306430 A1Global Ketone Limited
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Beta-hydroxybutyrate for the dietary management of depression1 Oct 2026US 2026/0294854 A1Laureate Institute For Brain Research
- Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption1 Oct 2026US 2026/0294917 A1Lucid Psycheceuticals Inc.
- Compositions and compounds including lithium orotate1 Oct 2026US 2026/0294962 A1Atlantis Software Company
Most cited
By later US patents
- Anti-angiogenic compositions and methods of use242US 6,544,544 B2Angiotech Pharmaceuticals, Inc. · 2003
- Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies166US 6,949,245 B1Genentech, Inc. · 2005
- BTK inhibitors and methods for their identification and use164US 6,160,010 AParker Hughes Institute · 2000
- Anti-angiogenic compositions and methods of use150US 6,506,411 B2Angiotech Pharmaceuticals, Inc. · 2003
- BTK inhibitors and methods for their identification and use113US 6,753,348 B2Parker Hughes Institute · 2004